We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Mr. Singh’s is a family-run business from East London, dedicated to making all-natural, 100% vegan Chilli sauces (ranked No. 1 in the UK by the Metro newspaper), award-winning cooking paste and Chili crisps. The company is gaining nationwide fame with demands for new flavours flowing in from its growing client base that includes independent pubs and retailers like WHSmith’s and Ocado. Mr. Singh’s newest and potential clients include a UK-based Vegan subscription box company and a company who owns 300+ petrol station shops around the UK. Owing to this success, Mr. Singh’s is looking at export channels to increase their presence beyond the UK.
days to go: Expired investment: £52,437
Holy Cow! are a modern, quirky brand producing an award winning range of Curry Sauces appealing to a wide British audience. They aim to mainstream the market of 'home cooking' style food and become a leading brand in the UK and around the world.
days to go: Expired investment: £94,002
StarStock are a drinks marketplace that enable suppliers to sell direct to wholesalers, pubs, shops, bars & restaurants nationwide. StarStock puts the suppliers in control of their products and listings, taking a small percentage of each sale. Suppliers set the prices, while we do the rest, arranging delivery of beers, ciders, wine and spirits.
days to go: Expired investment: £1,343,149
Whey Forward Health make innovative health and nutrition products. Since the launch in 2013 they have sold over 350,000 products. Promixx an original vortex mixer, battery powered, self-stirring protein shake maker, being their first product which is now sold in over 50 countries. They are now looking to launch two new shakes Regenerative and Morning Glory which are repeat purchase products. The investment will create two new websites operating on a subscription model and help them unlock their growth potential.
days to go: Expired investment: £292,399
East London Liquor Company export from east London to 20 countries worldwide. They have plans to launch in Ibiza, Toronto, Los angles, New York and Shanghai.  They also own their own restaurant. Since 2014 they have grown there team from 4 to 30 people. London dry gin has won many award and the East London Liquor Company produces over 12,000 bottles of gin a month.
days to go: Expired investment: £1,326,450
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £340,928
The Five Points Brewing Company (TFPBC) is one of London's best-known craft breweries that brews modern, flavourful, craft beer, The company asserts that its beers are stocked nationwide in pubs and across major chains like Waitrose, Tesco and Nando's. TFPBC claims that it has grown from £173,000 worth of sales in 2013 to £4.8 million in 2019. The company's first pub, The Pembury Tavern, has been graced with awards and recommendations from multiple entities. TFPBC argues that it has developed its e-commerce site in the wake of COVID-19 achieving online sales of over £300,000 from selling three million pints in draught, bottle and can form since March 2020. It also won the Champion Beer Of London 2019 Award. The company will use the investment to open its new on-site taproom with a large outdoor area for beer sales direct to the public, build a new flagship brewery site in Hackney, drive new sources of revenue whilst reducing costs, and maintain its commitment to East London
days to go: Expired investment: £841,392
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph